Cardio- and cerebrovascular risk with conventional synthetic disease-modifying antirheumatic drugs (CSDMARDS) in rheumatic arthritis (RA): a real-world comparative assesment

Cardio- and cerebrovascular risk with conventional synthetic disease-modifying antirheumatic drugs (CSDMARDS) in rheumatic arthritis (RA): a real-world comparative assesment

Библиографические подробности
Главные авторы:	Prats-Uribe, A, Illingens, B, Vizcaya, D, Weaver, J, Burn, E, Sawant, R, Marinier, K, Ryan, P, Prieto-Alhambra, D, European Hlth Data Evidence
Формат:	Conference item
Опубликовано:	2020

Схожие документы

Is Farming a Risk Occupation for Cardio-cerebrovascular Diseases? A Scoping Review on Cardio-cerebrovascular Disease Risk in Farmers
по: Hyeonjun Kim, и др.
Опубликовано: (2024-11-01)

VZV-specific T-cell levels in patients with rheumatic diseases are reduced and differentially influenced by antirheumatic drugs
по: David Schub, и др.
Опубликовано: (2018-11-01)

Inhibition of bone erosion, determined by high-resolution peripheral quantitative computed tomography (HR-pQCT), in rheumatoid arthritis patients receiving a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) plus denosumab vs csDMARD therapy alone: an open-label, randomized, parallel-group study
по: Naoki Iwamoto, и др.
Опубликовано: (2022-12-01)

Long-term efficacy of baricitinib in patients with rheumatoid arthritis who have had inadequate response to csDMARDs: results from ra-beyond up to 7 years of treatment
по: Caporali, R, и др.
Опубликовано: (2022)

Mg alloy cardio-/cerebrovascular scaffolds: Developments and prospects
по: Shaokang Guan, и др.
Опубликовано: (2023-11-01)

Improving Knowledge of Lactation Compatibility of Antirheumatic Medications Among Providers Who Care for Patients With Rheumatic Disease
по: Brooke S. Mills, и др.
Опубликовано: (2021-01-01)

Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study
по: Ronald F van Vollenhoven, и др.
Опубликовано: (2024-12-01)

Pleiotropic Effects of PCSK9 Inhibitors on Cardio-Cerebrovascular Diseases
по: Zhenzhen Li, и др.
Опубликовано: (2024-11-01)

Chinese herbal injection for cardio-cerebrovascular disease: Overview and challenges
по: Jiang Huajuan, и др.
Опубликовано: (2023-02-01)

Therapeutic Potential of Hydroxysafflor Yellow A on Cardio-Cerebrovascular Diseases
по: Xue Bai, и др.
Опубликовано: (2020-09-01)

Research Advances in Cardio-Cerebrovascular Diseases of Ligusticum chuanxiong Hort.
по: Dan Li, и др.
Опубликовано: (2022-01-01)

Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases
по: Jian-Hui Su, и др.
Опубликовано: (2021-08-01)

Iguratimod: Novel Molecular Insights and a New csDMARD for Rheumatoid Arthritis, from Japan to the World
по: Yuji Nozaki
Опубликовано: (2021-05-01)

Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis
по: Borja Hernández-Breijo, и др.
Опубликовано: (2019-02-01)

Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients
по: Judge, AD, и др.
Опубликовано: (2017)

South African Rheumatism and Arthritis Association 2024 guidelines for the use of biologic and targeted synthetic disease-modifying antirheumatic drugs
по: E van Duuren, и др.
Опубликовано: (2024-09-01)

Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases
по: C. Bazzani, и др.
Опубликовано: (2011-09-01)

miR-135b: An emerging player in cardio-cerebrovascular diseases
по: Yingchun Shao, и др.
Опубликовано: (2024-10-01)

Protective effects of catalpol on cardio-cerebrovascular diseases: A comprehensive review
по: Zixi Zhang, и др.
Опубликовано: (2023-10-01)

Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases
по: Mohan Li, и др.
Опубликовано: (2023-05-01)

Systems pharmacology for traditional Chinese medicine with application to cardio-cerebrovascular diseases
по: Yingxue Fu, и др.
Опубликовано: (2014-10-01)

The multifaceted biology of lncR-Meg3 in cardio-cerebrovascular diseases
по: Jing Li, и др.
Опубликовано: (2023-03-01)

Editorial: Bioactive substances-mediated targeted therapy of cardio-cerebrovascular diseases
по: Xiaoyong Tong, и др.
Опубликовано: (2023-02-01)

Inhaled nitric oxide: role in the pathophysiology of cardio-cerebrovascular and respiratory diseases
по: Davide Signori, и др.
Опубликовано: (2022-06-01)

Sinomenine in Cardio-Cerebrovascular Diseases: Potential Therapeutic Effects and Pharmacological Evidences
по: Meng-Wan Zhang, и др.
Опубликовано: (2021-10-01)

Genetic Predispositions Between COVID-19 and Three Cardio-Cerebrovascular Diseases
по: Jiang-Shan Tan, и др.
Опубликовано: (2022-03-01)

Seasonality and Cardio-Cerebrovascular Risk Factors for Benign Paroxysmal Positional Vertigo
по: Zhentang Cao, и др.
Опубликовано: (2020-04-01)

Tapering csDMARD or TNFi first: is the risk of flares different for ACPA-positive or ACPA-negative rheumatoid arthritis?
по: Annette H M van der Helm-van Mil, и др.
Опубликовано: (2024-08-01)

Association Between Blood Pressure Variation During Dialysis and Cardio‐Cerebrovascular Events
по: Zhenliang Fan, и др.
Опубликовано: (2025-01-01)

The adverse association of animal zinc intake with cardio-cerebrovascular and metabolic risk factors
по: Shu feng Zou, и др.
Опубликовано: (2024-03-01)

Application and risk prediction of thrombolytic therapy in cardio-cerebrovascular diseases: a review
по: Kexin Zhang, и др.
Опубликовано: (2023-09-01)

Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes
по: Dabei Fan, и др.
Опубликовано: (2018-05-01)

Frutos secos y riesgo cardio y cerebrovascular. Una perspectiva española
по: Nus¹ Meritxell, и др.
Опубликовано: (2004-05-01)

Cardio-cerebrovascular complications in COVID-19 patients: A retrospective cohort study
по: Kwan Hong, и др.
Опубликовано: (2022-12-01)

Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases
по: Jun-Xuan Lv, и др.
Опубликовано: (2017-12-01)

Home Monitoring Tools to Support Tracking Patients with Cardio–Cerebrovascular Diseases: Scientometric Review
по: Elisabeth Restrepo-Parra, и др.
Опубликовано: (2024-08-01)

Childhood asthma was associated with the presence of cardio-cerebrovascular diseases in US middle-aged and elderly
по: Hedi Zhang, и др.
Опубликовано: (2024-07-01)

MAIN RESULTS OF SCREENING METHODOLOGY TO REVEAL CARDIO- AND CEREBROVASCULAR PATHOLOGY IN PRIMARY OUTPATIENT CARE
по: I. V. Kim, и др.
Опубликовано: (2014-06-01)

Impact of an angulated aorto-septal relationship on cardio-cerebrovascular outcomes in patients undergoing hemodialysis.
по: Takafumi Nakayama, и др.
Опубликовано: (2024-01-01)

Impact of an angulated aorto-septal relationship on cardio-cerebrovascular outcomes in patients undergoing hemodialysis
по: Takafumi Nakayama, и др.
Опубликовано: (2024-01-01)